Safety and efficacy of 2‐weekly cabazitaxel in metastatic castration‐resistant prostate cancer

Publisher: John Wiley & Sons Inc

E-ISSN: 1464-410x|121|2|203-208

ISSN: 1464-4096

Source: BJU INTERNATIONAL, Vol.121, Iss.2, 2018-02, pp. : 203-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract